About the Study:
In March 2020 the WHO declared COVID-19 a pandemic. Since then, multiple vaccines have shown to be effective in preventing COVID-19 and received EUA approval from the FDA. The duration of protection after COVID-19 infection or vaccination is unknown, and the virus continues to evolve with new highly contagious variants. This study will be evaluating an investigational vaccine regimen to prevent COVID-19 and some of its variant strains.
The purpose of this study is to evaluate the safety and immunogenicity of COVID-19 mRNA vaccine against variant strains of COVID-19.
The study will last approximately 12-14 months with up to 9 visits to our office. There is a zero chance of placebo in this study.
Study-related care is available to participants at no cost and health insurance is not required nor needed. Compensation for time and travel is available up to $150 per visit to those who qualify.
To qualify for this study, you must be between the ages of 18-85 years old and have not previously received a COVID-19 vaccine.
This study is part of our RCR Refer a Friend Program. Learn more about the program here.
- Be between the ages of 18-85 years old
- Have not previously received a COVID-19 vaccine
- Please note, other conditions apply